Macrophage colony-stimulating factor rapidly enhances beta-migrating very low density lipoprotein metabolism in macrophages through activation of a Gi/o protein signaling pathway

J Biol Chem. 2000 Nov 17;275(46):35807-13. doi: 10.1074/jbc.M001797200.

Abstract

Previous studies have examined lipoprotein metabolism by macrophages following prolonged exposure (>24 h) to macrophage colony-stimulating factor (M-CSF). Because M-CSF activates several signaling pathways that could rapidly affect lipoprotein metabolism, we examined whether acute exposure of macrophages to M-CSF alters the metabolism of either native or modified lipoproteins. Acute incubation of cultured J774 macrophages and resident mouse peritoneal macrophages with M-CSF markedly enhanced low density lipoproteins (LDL) and beta-migrating very low density lipoproteins (beta-VLDL) stimulated cholesteryl [(3)H]oleate deposition. In parallel, M-CSF treatment increased the association and degradation of (125)I-labeled LDL or beta-VLDL without altering the amount of lipoprotein bound to the cell surface. The increase in LDL and beta-VLDL metabolism did not reflect a generalized effect on lipoprotein endocytosis and metabolism because M-CSF did not alter cholesterol deposition during incubation with acetylated LDL. Moreover, M-CSF did not augment beta-VLDL cholesterol deposition in macrophages from LDL receptor (-/-) mice, indicating that the effect of M-CSF was mediated by the LDL receptor. Incubation of macrophages with pertussis toxin, a specific inhibitor of G(i/o) protein signaling, had no effect on cholesterol deposition during incubation with beta-VLDL alone, but completely blocked the augmented response promoted by M-CSF. In addition, incubation of macrophages with the direct G(i/o) protein activator, mastoparan, mimicked the effect of M-CSF by enhancing cholesterol deposition in cells incubated with beta-VLDL, but not acetylated LDL. In summary, M-CSF rapidly enhances LDL receptor-mediated metabolism of native lipoproteins by macrophages through activation of a G(i/o) protein signaling pathway. Together, these findings describe a novel pathway for regulating lipoprotein metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Cell Line
  • Cholesterol Esters / metabolism
  • Heterotrimeric GTP-Binding Proteins / metabolism*
  • Intercellular Signaling Peptides and Proteins
  • Iodine Radioisotopes
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, VLDL / metabolism*
  • Macrophage Colony-Stimulating Factor / pharmacology*
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / metabolism*
  • Mice
  • Mice, Inbred Strains
  • Mice, Knockout
  • Peptides
  • Protein Binding / drug effects
  • Rabbits
  • Receptors, LDL / genetics
  • Receptors, LDL / metabolism
  • Recombinant Proteins / pharmacology
  • Signal Transduction / drug effects*
  • Wasp Venoms / pharmacology
  • Wortmannin

Substances

  • Androstadienes
  • Cholesterol Esters
  • Intercellular Signaling Peptides and Proteins
  • Iodine Radioisotopes
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Peptides
  • Receptors, LDL
  • Recombinant Proteins
  • Wasp Venoms
  • acetyl-LDL
  • mastoparan
  • Macrophage Colony-Stimulating Factor
  • Heterotrimeric GTP-Binding Proteins
  • Wortmannin